Ondine Biomedical Inc. announced that a UK-based study demonstrated a significant reduction in antibiotic use following sinus surgeries where Steriwave®? was used for pre-surgical nasal decolonization. Professor Claire Hopkins, Professor of Rhinology at King's College London and Consultant ENT Surgeon at Guy's & St Thomas' NHS Foundation Trust, has reported a retrospective study showing that using Steriwave in her endoscopic sinus surgery patients led to antibiotic use across all her patients dropping from 22% to less than 5% - a 77% reduction.

Professor Hopkins has been using Steriwave routinely to nasally decolonise her endoscopic sinus Surgery patients at London Bridge Hospital since 2021. This is an important finding to allay potential concerns as to a possible side-effect of Steriwave treatment, which has been used in over 150,000 patients with no serious adverse events reported. Steriwave was selected as a 2024 SPIE Prism Awards finalist in the 'Biomedical' category.